SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-091133
Filing Date
2020-08-06
Accepted
2020-08-06 07:39:48
Documents
3
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2026360d3_8k.htm 8-K 18577
2 EXHIBIT 99.1 tm2026360d3_ex99-1.htm EX-99.1 77785
3 GRAPHIC tm2026360d3_ex99-1img001.jpg GRAPHIC 6887
  Complete submission text file 0001104659-20-091133.txt   107245
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 201079856
SIC: 2834 Pharmaceutical Preparations